Clin2
NCT07686861Possibly a fitNot yet recruiting

Antibiotics plus probiotics for cirrhosis-related belly infection

Cirrhosis With Spontaneous Bacterial Peritonitis

Part of Digestive system, Infections clinical trials.

This trial tests whether adding a probiotic (Bifidobacterium) to standard antibiotic treatment works better for treating spontaneous bacterial peritonitis (an infection in the belly fluid caused by liver cirrhosis) and preventing it from coming back.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
360 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You are between 18 and 80 years old.
  • You have cirrhosis with ascites (fluid in the belly) and have been diagnosed with a bacterial infection in that fluid.
  • You have not taken antibiotics or probiotics in the last week.
  • Your liver and kidney function are good enough, with certain blood test levels within range (like platelets, hemoglobin, and creatinine).
  • You are willing to sign a consent form and follow the study plan.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06871111Recruiting· Phase 1
Bacteria treatment study for liver disease patients

This trial tests whether giving a mixture of helpful bacteria can improve gut health in people hospitalized with serious liver problems. It aims to see if restoring these bacteria can help with recovery.

Chicago, Illinois
NCT04161768Recruiting· Phase 3
Antibiotic pill study to prevent repeat belly infection in liver disease

This study tests whether taking norfloxacin plus itopride helps prevent another episode of spontaneous bacterial peritonitis (a serious belly infection) in people with cirrhosis and fluid buildup in the abdomen. It compares that combo to norfloxacin alone to see which approach better lowers repeat infections.

Tanta
NCT06778616Not yet recruiting
Stomach infection return in liver disease patients study

This study looks at why some patients with cirrhosis get a serious stomach infection called SBP more than once. It may help doctors predict and prevent repeat infections.

Asyut, Asyut Governorate
NCT06511492Not yet recruiting
Tracking resistant bacteria in cirrhosis patients

This study monitors patients with worsening cirrhosis for certain hard-to-treat bacteria in the gut. It aims to understand how these bacteria spread and how to prevent infections.

NCT06995846Enrolling by invitation
Testing bacterial DNA in belly fluid to diagnose SBP in cirrhosis

This study tests a new way to detect bacteria in the fluid in your belly (ascites) to see if it can quickly diagnose a serious infection called spontaneous bacterial peritonitis (SBP) in people with cirrhosis. If you have cirrhosis and ascites, this trial may help improve how fast infections are found.

Beijing
NCT07116369Not yet recruiting
Predicting infections in cirrhosis with ascites

This trial looks at whether simple blood tests (platelet count, sodium, and a liver score) can predict a serious infection called spontaneous bacterial peritonitis (SBP) in people with cirrhosis and fluid buildup in the belly (ascites). If successful, it could help doctors catch this infection earlier.

Sohag

Hear when a new Cirrhosis With Spontaneous Bacterial Peritonitis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.